Natural products that elicit discomfort or pain represent invaluable tools for probing molecular mechanisms underlying pain sensation 1 . Plant-derived irritants have predominated in this regard, but animal venoms have also evolved to avert predators by targeting neurons and receptors whose activation produces noxious sensations 2-6 . As such, venoms provide a rich and varied source of small molecule and protein pharmacophores 7,8 that can be exploited to characterize and manipulate key components of the pain-signalling pathway. With this in mind, here we perform an unbiased in vitro screen to identify snake venoms capable of activating somatosensory neurons. Venom from the Texas coral snake (Micrurus tener tener), whose bite produces intense and unremitting pain 9 , excites a large cohort of sensory neurons. The purified active species (MitTx) consists of a heteromeric complex between Kunitz-and phospholipase-A2-like proteins that together function as a potent, persistent and selective agonist for acid-sensing ion channels (ASICs), showing equal or greater efficacy compared with acidic pH. MitTx is highly selective for the ASIC1 subtype at neutral pH; under more acidic conditions (pH , 6.5), MitTx massively potentiates (.100-fold) proton-evoked activation of ASIC2a channels. These observations raise the possibility that ASIC channels function as coincidence detectors for extracellular protons and other, as yet unidentified, endogenous factors. Purified MitTx elicits robust pain-related behaviour in mice by activation of ASIC1 channels on capsaicin-sensitive nerve fibres. These findings reveal a mechanism whereby snake venoms produce pain, and highlight an unexpected contribution of ASIC1 channels to nociception.
Natural products that elicit discomfort or pain represent invaluable tools for probing molecular mechanisms underlying pain sensation 1 . Plant-derived irritants have predominated in this regard, but animal venoms have also evolved to avert predators by targeting neurons and receptors whose activation produces noxious sensations [2] [3] [4] [5] [6] . As such, venoms provide a rich and varied source of small molecule and protein pharmacophores 7, 8 that can be exploited to characterize and manipulate key components of the pain-signalling pathway. With this in mind, here we perform an unbiased in vitro screen to identify snake venoms capable of activating somatosensory neurons. Venom from the Texas coral snake (Micrurus tener tener), whose bite produces intense and unremitting pain 9 , excites a large cohort of sensory neurons. The purified active species (MitTx) consists of a heteromeric complex between Kunitz-and phospholipase-A2-like proteins that together function as a potent, persistent and selective agonist for acid-sensing ion channels (ASICs), showing equal or greater efficacy compared with acidic pH. MitTx is highly selective for the ASIC1 subtype at neutral pH; under more acidic conditions (pH , 6.5), MitTx massively potentiates (.100-fold) proton-evoked activation of ASIC2a channels. These observations raise the possibility that ASIC channels function as coincidence detectors for extracellular protons and other, as yet unidentified, endogenous factors. Purified MitTx elicits robust pain-related behaviour in mice by activation of ASIC1 channels on capsaicin-sensitive nerve fibres. These findings reveal a mechanism whereby snake venoms produce pain, and highlight an unexpected contribution of ASIC1 channels to nociception.
To identify novel toxins that activate nociceptors, we screened venoms from a variety of snake species for their ability to depolarize specific subpopulations of somatosensory neurons using calcium imaging as a functional readout. Among these, venom from the Texas coral snake, which elicits intense acute pain associated with local oedema and inflammation 9 , produced clear and robust activation of most, but not all, neurons cultured from trigeminal ganglia of newborn (P0-P2) rats ( Fig. 1a, b) . In contrast, coral snake venom had no effect on sympathetic neurons cultured from superior cervical ganglia (not shown).
We next fractionated the crude venom using reversed-phase chromatography ( Supplementary Fig. 1 ) to identify the active component(s). No single fraction excited sensory neurons, but when re-pooled the individual fractions fully reconstituted activity observed with the crude venom, suggesting a requirement for multiple components. Pair-wise analysis of these fractions identified two components (MitTx-a and MitTx-b), which could be purified to near-homogeneity with subsequent chromatographic steps, as assessed by gel filtration chromatography, SDS-polyacrylamide gel electrophoresis and mass spectrometry (not shown). These two toxins together proved necessary and sufficient to recapitulate activity of the crude venom. Mass spectrometry and amino (N)-terminal Edman sequencing showed that both MitTx-a and MitTx-b are proteinaceous in nature, and partial amino-acid sequences derived from these analyses were used to clone full-length complementary DNAs (cDNAs) from the coral snake venom gland. The deduced amino-acid sequences revealed patterns of cysteine residues that classify MitTx-a and MitTx-b as Kunitz type and phospholipase A2 (PLA2)-like proteins, respectively ( Fig. 1c and Supplementary Fig. 1 ). Indeed, these families of cysteine-rich disulphide-bonded proteins are prevalent components of various snake venoms 8 , and in some cases have been shown to form biochemical complexes 10 .
To determine whether MitTx-a and MitTx-b form a heteromeric complex, we used isothermal titration calorimetry to detect any such molecular interaction. We observed a substantial exothermic reaction (change in enthalpy DH 5 218.9 6 1.3 kcal mol 21 ) upon mixing, resulting from a high-affinity binding event (dissociation constant K d 5 12.2 6 3.1 nM) with 1:1 stoichiometry (n 5 1.02 6 0.05) ( Fig. 1d ). These biochemical results are consistent with our physiological analysis showing that neither MitTx-a nor MitTx-b activated sensory neurons alone, whereas a robust and immediate rise in intracellular calcium was produced when both components were added simultaneously or sequentially (in either order) ( Fig. 1e ). Moreover, even a brief washout period between sequential applications prevented activation ( Fig. 1f ), suggesting that only the MitTx-a/b complex forms a persistent and productive interaction with its physiological target.
Having defined the molecular nature of the toxin components, we next sought to elucidate its mechanism of action on sensory neurons. As the MitTx-b component lacks critical catalytic residues normally found in the active site of related PLA2 enzymes 11 , phospholipase activity seemed unlikely to contribute to neuronal excitation. In fact, we failed to detect PLA2 activity associated with any component, together or alone ( Supplementary Fig. 1 ), suggesting that the toxin is not producing neuronal depolarization simply by degrading the plasma membrane (consistent with the observed action on a subset of somatosensory neurons). Nevertheless, it is possible that MitTx-b maintains some lipid-binding character from its PLA2 lineage, which could aid in effecting neuronal depolarization.
To gain clues about the cellular mechanism of toxin action, we performed a detailed biophysical analysis of toxin-evoked responses. Whole-cell patch-clamp recordings showed that purified MitTx-a/b complex (hereafter referred to as MitTx) produced robust currents in a subset of trigeminal neurons. These currents were characterized by a linear current-voltage relationship and high permeability to Na 1 versus Cs 1 ions (P Na membrane currents in oocytes expressing the ASIC1b subtype ( Fig.  2b , c). Consistent with our results using cultured neurons, neither MitTx-a nor MitTx-b was active on its own, but robust responses were evoked when both components were applied to oocytes, whether pre-mixed or mixed in situ. Furthermore, the ENaC/ASIC blocker, amiloride, abolished these responses. When applied at maximal concentration, MitTx elicited responses exceeding those produced by saturating doses of extracellular protons. Whereas protons elicit very transient responses, those evoked by toxin were dramatically prolonged, reflecting both lack of desensitization and slow reversibility after washout ( Fig. 2c ).
Among ASIC subtypes, the most robust toxin-evoked responses were observed with ASIC1a or 1b based on potency (half-maximum effective concentration EC 50 5 9.4 6 1.3 and 23 6 3.6 nM, respectively), efficacy (relative to protons) and persistence of action ( Fig. 2d and Supplementary Fig. 2 ). MitTx must interact with an extracellular region of the channel because responses were observed in the outside-out (but not inside-out) configuration when toxin was applied to patches excised from ASIC1a-expressing CHO cells (not shown). Moreover, at least for ASIC1a, toxin potency (9 nM) is probably limited by the affinity of a/b complex formation (12 nM, Fig. 1d ) and not by the toxin-channel interaction itself.
The ASIC3 subtype was also MitTx sensitive, but required ,100fold higher toxin concentration to achieve appreciable activation (EC 50 5 830 6 250 nM). This lower potency was accompanied by relatively slow activation and fast washout kinetics compared with those observed with ASIC1a or 1b ( Supplementary Fig. 2 ). By comparison, ASIC2a showed very weak activation by toxin, never achieving more than 10% efficacy compared with proton-evoked responses ( Fig. 2d, e ). Despite this anaemic response, the toxin produced a remarkable potentiation of acid-evoked currents, greatly enhancing both potency and efficacy of protons ( Fig. 2e, f) . Indeed, as the extracellular pH drops below neutrality, the toxin itself becomes an excellent ASIC2a agonist, essentially enhancing the potency of protons by three orders of magnitude. Two remaining ASIC family members, 2b and 4, do not produce proton-activated channels on their own, and we did not observe MitTx-evoked responses in oocytes expressing these subtypes. As a further testament to toxin specificity, MitTx produced neither activation nor persistent inhibition when applied to a diverse range of cloned ion channels, including voltage-gated, ENaC, TRP, P2X or 5-HT 3 channels ( Supplementary Fig. 3 ). Additionally, MitTx activated the same percentage of trigeminal neurons cultured from wild-type or TRPV1/TRPM8/TRPA1 triple knockout mice ( Supplementary Fig. 4 ).
M. tener tener is not the only coral snake species to express ASICactivating toxins; venom from the Brazilian coral snake (Micrurus frontalis) activated a similar cohort of cultured rat trigeminal sensory neurons, or oocytes expressing cloned ASIC1a channels (Supplementary Fig. 5 ). Interestingly, ASIC1a is also targeted by a peptide toxin from tarantula (PcTx1), but in this case, the toxin serves as a functional antagonist of proton-evoked responses by locking the channel in a desensitized state 15, 16 . ASIC1a channels blocked by PcTx1 could not be activated by MitTx, and MitTx-activated channels could not be blocked by PcTx1 (Fig. 2g, h ), suggesting physical or functional occlusion of toxin action.
We next used patch-clamp recording methods to determine whether MitTx-evoked neuronal responses exhibit properties consistent with an ASIC-mediated mechanism. Sensory neurons show both transient and sustained proton-evoked responses, with the former being mediated primarily by ASIC channels and the latter by capsaicinsensitive TRPV1 channels 17, 18 . We found that all MitTx-sensitive neurons exhibited transient responses to extracellular protons (pH 4), toxin responses were blocked by amiloride and eliminated in Na 1 -free d, Isothermal titration calorimetry reveals formation of high-affinity MitTx-a/b complex with 1:1 stoichiometry. e, MitTx-a and MitTx-b have no effect individually, but recapitulate activity of whole venom when applied together to trigeminal ganglia neurons. f, Average calcium response from more than 100 randomly selected trigeminal ganglia neurons that also responded to high extracellular potassium (Hi K 1 , 100 mM KCl). Activation by MitTx-a/b (300 nM each) only occurs when both toxins are present.
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perfusate, and the relative magnitude of toxin-to-proton evoked responses resembled those observed in transfected mammalian (CHO) cells expressing the cloned rat ASIC1a or 1b channels ( Fig. 3a, b ). Further evidence that ASIC1 is the predominant target of MitTx came from analysis of electrophysiological responses in trigeminal neurons from newborn ASIC1-or ASIC3-deficient mice 19, 20 . The percentage of toxin-sensitive cells from ASIC1 2/2 mice was greatly diminished compared with wild-type or ASIC3 2/2 animals ( Fig. 3c, d ). Using calcium imaging to sample a larger population of neurons, we found that responses to moderate toxin concentrations (20 nM) were completely absent in trigeminal neurons cultured from ASIC1 2/2 mice, but unperturbed in those from ASIC3 2/2 animals ( Fig. 3e-g ). Only at substantially higher toxin concentrations (600 nM; exceeding the EC 50 for ASIC1 by at least 30-fold) did we observe a relatively small subset of toxin-sensitive neurons in ASIC1 2/2 cultures. These residual toxin responses were eliminated when depolarization-evoked calcium influx was suppressed in Na 1 -free perfusate ( Supplementary Fig. 6 ), consistent with Ca 21 -impermeant ASIC2 and/or ASIC3 subtypes accounting for the activity. Indeed, ASIC3 2/2 cultures showed a small but significant diminution in the percentage of neurons responding to 600 nM MitTx (Fig. 3g) .
The role of ASIC channels in pain has focused primarily on ASIC3 given its somatosensory neuron-specific pattern of expression 13 . MitTx provides a novel tool with which to determine whether ASIC1 and ASIC1-expressing neurons also contribute to nociception. 
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Injection of MitTx into the hindpaw of wild-type mice produced robust nocifensive (pain-related) behaviour scored as a characteristic licking response (Fig. 4a ). In the same animals, we observed abundant Fos protein expression in superficial laminae of the ipsilateral dorsal spinal cord, demonstrating engagement of nociceptive pathways (Fig. 4b) . These responses were diminished in ASIC1-deficient mice, but persisted in ASIC3 2/2 animals, demonstrating a predominant contribution of ASIC1 channels to toxin-evoked nocifensive behaviour. Are these responses mediated through a well-characterized population of nociceptors? To address this question, we first examined MitTx-sensitive neurons for expression of relevant molecular markers of subpopulations of nociceptors. One-third of toxin-sensitive neurons expressed TRPV1, whereas a much smaller group (11%) were labelled by isolectin B4, which in mice marks a population of TRPV1-negative, non-peptidergic C-fibres. Most (53%) toxin-sensitive neurons immunostained for the NF200 neurofilament, placing them among the subpopulation of medium-to-large diameter neurons with myelinated axons (Fig. 4c ). As many large diameter sensory neurons respond to innocuous mechanical stimulation, these histological results suggest that functional ASIC1 channels are expressed by both nociceptive and non-nociceptive somatosensory neurons. Next, we asked whether MitTx elicits nocifensive responses in mice in which the central terminals of TRPV1-expressing nociceptors have been selectively ablated through spinal (intrathecal) injection of capsaicin 21 . Indeed, these animals showed a complete loss of toxin-evoked behaviour and Fos immunoreactivity in the spinal cord ( Fig. 4d) , demonstrating that the painful effects of MitTx are mediated entirely by a relatively small cohort (less than a third) of ASIC1-expressing nerve fibres.
Bites and stings from venomous creatures produce pain to ward off predators [2] [3] [4] , and thus it stands to reason that some toxins have evolved to efficiently target elements of the pain pathway. In fact, bites from some coral snake species are well known to elicit excruciating pain requiring hospitalization and administration of opiate analgesics 9, 22 . Our results show that MitTx has evolved from Kunitz-type and PLA2like protein scaffolds to evoke intense and persistent pain by producing robust and long-lasting activation of ASIC1 channels on the nociceptive terminals of mammalian, avian or serpentine predators. Just as capsaicin and some spider toxins highlight the importance of TRPV1 in pain sensation, so MitTx implicates ASIC1 channels in this protective sensory modality, further illustrating the power of natural products in identifying key components and therapeutic targets of nociceptive signalling pathways.
In light of its selective expression within somatosensory ganglia and a well-documented contribution to ischaemic pain, studies of ASIC channels in nociception have focused primarily on the ASIC3 subtype 13, [23] [24] [25] [26] . The extremely persistent (non-desensitizing) and selective nature of MitTx action has enabled us to functionally isolate ASIC1 channels and reveal their contribution to pain sensation through the activation of TRPV1-expressing neurons. This nociceptor population has been suggested to constitute a 'labelled line' required for acute detection of noxious heat, as well as tissue injury-evoked pain hypersensitivity 1, 21 . Activation of ASIC1 on these nerve fibres may contribute to the non-TRPV1 component of proton-mediated sensitization associated with tissue acidosis and inflammatory pain. ASIC1 is also expressed by non-nociceptive somatosensory neurons, as well as other neural and non-neural tissues 14, 20, 24, 27 . Thus, MitTx represents a novel class of pharmacological probes with which to elucidate the contributions of ASIC channels to a variety of physiological processes. Finally, it is intriguing that MitTx can potentiate proton efficacy at some ASIC subtypes (most notably ASIC2a) by 
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two or three orders of magnitude. That is to say, MitTx reveals the fact that protons only activate ASIC2a channels to less than 10% of maximal open probability, suggesting that protons do not exploit the full potential of ASIC2a as a ligand-gated channel. Although small FMRF-amide-like peptides have been shown to potentiate proton-gated currents through ASIC1 and ASIC3 (primarily by slowing desensitization) 25, 28 , the profound enhancing effects mediated by MitTx hint at the existence of other, more potent physiological modulators for this class of excitatory channels.
METHODS SUMMARY
MitTx-a and MitTx-b were purified from crude M. tener tener venom (National Natural Toxin Research Center, Texas A&M University-Kingsville) using multiple reversed-phase high-performance liquid chromatography (HPLC) steps and purity assessed by mass spectrometry and gel filtration chromatography. Partial toxin sequences were determined by Edman degradation and/or de novo tandem mass spectrometry sequencing analysis and used to design degenerate primers for cloning full-length MitTx-a and MitTx-b cDNAs from M. t. tener venom gland library. PcTx1 was purified from Psalmopoeus cambridgei venom (SpiderPharm) and M. frontalis venom was purchased from Sigma. ASICs were cloned from rat trigeminal ganglion or brain cDNA libraries (except mouse ASIC2b, which was provided by M. Welsh). For isothermal titration calorimetry (ITC) experiments, MitTx-b (3-10 mM) was titrated into MitTx-a (0.3-1 mM) at 15 uC. Molecular biology, neuronal dissociation, cell culture, calcium imaging and electrophysiological experiments were conducted essentially as described 6 . P Na 
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Toxin purification. Crude M. tener tener venom, pooled from multiple specimens, was provided by the National Natural Toxins Research Center, Texas A&M University-Kingsville, Texas, USA. Lyophilized venom was dissolved in water to 100 mg ml 21 , diluted 30-fold into 20% acetonitrile containing 0.1% trifluoroacetic acid (TFA), filtered through a 0.1-mm centrifugal filter unit (Millipore) and fractionated by reversed-phase HPLC. Up to 20 mg venom was loaded onto a semi-preparative C18 column (Vydac model 218TP510), and eluted with a 20-min linear gradient (18-36% acetonitrile; 3 ml min 21 ). Fractions containing predominantly MitTx-a were diluted twofold with 0.1% TFA, injected onto an analytical PLRP-S column (Varian PL1512-5501) and separated with an 8-min linear gradient (27-34% acetonitrile; 0.8 ml min 21 ); MitTx-a-containing fractions were again diluted, injected onto an analytical C18 column (Vydac 218TP54) and separated with a 20-min linear gradient (18-36% acetonitrile; 0.8 ml min 21 ). MitTx-b fractions from the semi-preparative run were diluted, applied to an analytical C18 column (Vydac 218TP54) and separated with a 7-min linear gradient (30-36% acetonitrile; 0.8 ml min 21 ). All HPLC buffers contained 0.1% TFA, and all purifications were performed at room temperature. Purified fractions were lyophilized then dissolved in water, aliquoted, and stored at 280 uC. Protein concentration was determined using calculated extinction coefficient at 280 nm (http://us.expasy.org /tools/protparam.html). PcTx1 was purified from Psalmopoeus cambridgei venom (SpiderPharm) using two sequential HPLC steps consisting of 114-min linear gradient (0-54% acetonitrile on a semi-preparative C18 column) followed by the same gradient on an analytical C18 column (as above). M. frontalis venom was purchased from Sigma. Sequence determination. Toxin masses were determined using a Bruker Apex III ESI-Q-FTICR mass spectrometer, and the N-terminal sequencing was performed on an Applied Biosystems 492 Procise Sequencer previously described 6 . Edman degradation yielded partial sequence (NLNQFRLMIKCTNDRV…) for MitTx-b, but not MitTx-a owing to modified (pyroglutamic acid) N terminus. Partial MitTx-a sequence was determined de novo by tandem mass spectrometry sequencing analysis. After reduction under acidic conditions (0.1% formic acid, 5 mM TCEP for 24 h at 37 uC) MitTx-a was subjected to collision-induced dissociation (CID), higherenergy collisional dissociation (HCD) and electron transfer dissociation (ETD) analyses using an LTQ-Orbitrap mass spectrometer (Thermo Fisher). Data were analysed manually, yielding the N-terminal sequence as well as a shorter internal sequence fragment (,Q[L/I]RPAFCYEDPPFFQKCGAFVDSYYF... and …HFFYGQCDV…).
Partial protein sequences were used to clone full-length MitTx-a and MitTx-b cDNAs. RNA was extracted from two M. t. tener venom glands using TRIZOL reagent (Invitrogen), then isolated by chloroform extraction and isopropanol precipitation. A cDNA library was generated for use in 59 and 39 rapid amplification of cDNA ends (RACE) reactions using SMARTer RACE cDNA Amplification Kit (Clontech). Primers derived from biochemically determined sequences and, for MitTx-b, taking advantage of conservation in reported Micrurus PLA2 sequences, small fragments of MitTx-a and MitTx-b sequences were amplified by PCR and then used to design gene-specific 39 and 59 RACE primers. RACE products were sequenced individually after insertion into TOPO vector (Invitrogen) , and each sequence fragment was confirmed by multiple sequencing reads and multiple RACE primer sets. The cDNA-derived peptide sequence predicted the observed molecular weight of the purified toxins after consideration of the post-translational modifications (N-terminal cyclization and disulphide bond formation). Calorimetry. MitTx-a and MitTx-b were diluted into ITC buffer (150 mM NaCl, 1 mM CaCl 2 , 10 mM HEPES, adjusted to pH 7.4 with NaOH). Toxin aliquots were diluted with water before dilution with ITC buffer to maintain the same dilution factor. Diluted toxin solutions were centrifuged (65,000g for 30 min at 4 uC), degassed (5 min at 15 uC), and loaded into a VP-ITC Microcalorimeter (MicroCal). MitTx-b (3-10 mM) was titrated into MitTx-a (0.3-1 mM) following a schedule of one 4-ml injection followed by 29 injections of 10 ml, each spaced by 5 min. Titrations were conducted at 15 uC. After manual baseline correction, total heat released per injection was calculated by integrating over the full injection time period. Heat of dilution was estimated by the final titration points and subtracted from baseline. Linear baseline values were confirmed by titration of MitTx-b into buffer. Data were processed and fit to a single-site binding model using Origin version 7 (MicroCal). Reported values are averages of three independent experiments. Molecular biology. Full-length (not including untranslated regions) ASIC1a, 1b, 2a, 3 and 4 were cloned from rat trigeminal ganglion or brain cDNA libraries into pCDNA3.1 (Invitrogen) . The mouse ASIC2b clone was provided by M. Welsh, and rat ENaC clones were provided by D. Pearce. All constructs were confirmed by DNA sequencing. Other constructs and RNA synthesis have been previously described 6 .
